Wellspect Launches Surity Female Catheter for Urinary Care

MOLNDAL, Sweden—Wellspect HealthCare, a global provider of continence care solutions, announced the United States launch of the Surity Female External Catheter, a new non-invasive solution designed to support women living with severe urinary incontinence. 

The company said Surity is designed to be non-invasive, easy-to-place catheter with compatible urine collection systems.

“Severe urinary incontinence affects millions of women, many of whom live with multiple health conditions,” said Chris Schlenk, group vice president of Wellspect HealthCare. “The impact of severe urinary incontinence reaches far beyond the inconvenience of leaks, contributing to sleep loss, emotional distress and exhaustion for both patients and their caregivers. As leaders in continence care, we’re determined to support patients and caregivers by offering a reliable and accessible management option designed to restore comfort, rest and confidence to those who have lived with these silent struggles for too long.”

Wellspect said Surity was engineered to prevent leakage, protect skin and support extended overnight use, and it aims to help women and their caregivers confidently manage incontinence care through integration into daily routines. The device is intended to make management of severe urinary incontinence more predictable, addressing a significant gap in continence care across aging, neurologic and mobility-limited populations. 

Wellspect said it will launch the advanced Surity Urinary Management System and male external catheter later this year. Surity Female External Catheter is now available for home purchase at surity.care and will soon be available to health care institutions.